TB-500 (Thymosin Beta-4) is a 43 amino acid peptide sequence. In animal models, Thymosin Beta-4 has been shown to improve blood vessel growth, regulate wound healing, decrease inflammation, and reduce oxidative damage in the heart and central nervous system. Thymosin-beta-4 has a role in protection, tissue repair, regeneration and remodeling of injured or damaged tissues. It is also of active interest in anti-aging research. Buy TB-500 2mg

SLU-PP-332 is an experimental compound designed to mimic the metabolic effects of exercise by activating estrogen-related receptors (ERRs), particularly ERRα, ERRβ, and ERRγ. This activation leads to increased energy expenditure, enhanced fatty acid oxidation, and improved mitochondrial function.

BPC-157 5mg, TB-500 (Thymosin Beta-4) 5mg, GHK-Cu 20mg 
(30mg Total Glow Blend) Click Here BPC-157, TB-500, GHK-Cu (Glow Blend) 60mg Mechanisms and Synergy BPC-157: A stable gastric pentadecapeptide shown to accelerate angiogenesis, fibroblast migration, and epithelial repair via modulation of VEGFR2, FAK-paxillin pathways, and nitric oxide signaling. It enhances tendon, muscle, and intestinal healing in preclinical models. TB-500 (Thymosin Beta-4): A 43-amino acid actin-sequestering peptide that promotes tissue regeneration through cell migration, angiogenesis (via VEGF upregulation), and anti-inflammatory effects. It mobilizes progenitor cells and accelerates repair of myocardium, dermis, and connective tissue. GHK-Cu: A copper-binding tripeptide (glycyl-L-histidyl-L-lysine) that stimulates wound healing, collagen synthesis, and hair growth. It modulates gene expression linked to tissue remodeling and exerts antioxidant and anti-inflammatory effects through TGF-β and metalloproteinase regulation. Synergistic Benefits:
Combined research with BPC-157, TB-500, and GHK-Cu may offer synergistic tissue regeneration and anti-inflammatory benefits by concurrently activating multiple repair pathways: Angiogenesis: TB-500 and BPC-157 both promote VEGF-mediated vascularization, while GHK-Cu enhances endothelial cell proliferation. Cellular migration and matrix remodeling: TB-500 improves actin polymerization and cellular motility; GHK-Cu and BPC-157 stimulate ECM production and fibroblast activity. Anti-inflammatory modulation: All three reduce oxidative stress and cytokine-driven inflammation, potentially improving healing in chronic or complex injuries. This multifactorial synergy suggests enhanced efficacy in musculoskeletal, dermatological, and post-surgical recovery applications.

Orforglipron (LY3502970, OWL833) is a highly orally bioavailable small-molecule partial activator of the GLP-1 receptor. Through G-protein–coupled pathways, it replicates incretin effects while maintaining receptor sensitivity. Studies show it promotes improved body composition, metabolic balance, better glucose control, and enhanced beta-cell protection. It also helps balance cholesterol and inflammatory markers, contributing to cardiovascular and metabolic wellness. These findings suggest Orforglipron may play an important role in supporting overall metabolic efficiency and cellular resilience.

Thymosin Beta-4 Fragment (1-4) (Ac-SDKP) is a naturally occurring tetrapeptide from thymosin beta-4 that exhibits anti-inflammatory, pro-angiogenic, and anti-scarring properties. It has potential as a therapeutic agent for conditions like cardiovascular disease, kidney/ liver fibrosis, and inflammatory bowel disease. It may also provide a more natural approach to treating high blood pressure due to its link with angiotensin-converting enzyme.

Each capsule contains 500mcg Stable BPC-157 Arginate Form and 2.5mg Thymosin Beta-4 Fragment (Ac-SDKP) Both Thymosin Beta 4 Fragment (Ac-SDKP) and Stable BPC-157 Arginate have shown a significant increase in oral bioavailability and stability. These two peptides have undergone extensive research for their ability to promote wound healing and increase the rate of tissue repair. BPC-157 and TB-500 research has shown them to significantly improve the health of the nervous system by reducing inflammation and oxidative stress, protecting cells that support neurons and improving the migration of cells involved with tissue repair. Much research is also being done with these two peptides in the setting of traumatic brain injury, stroke, and neurodegenerative diseases like ALS and Alzheimer’s.

Peptide Sciences OS-01 peptide is not affiliated with, endorsed by, approved by, or otherwise associated with OneSkin’s OS-01 products and registered OS-01® trademark. OS-01 is an AMP-activated protein kinase (AMPK) activator that modulates cellular energy homeostasis and metabolic function. AMPK, a central regulator of energy balance, is activated in response to low intracellular ATP levels, enhancing glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. OS-01 stimulates AMPK phosphorylation, leading to increased ATP production, improved insulin sensitivity, and enhanced autophagic flux, thereby promoting cellular repair and longevity. This compound has been shown to mitigate oxidative stress by downregulating reactive oxygen species (ROS) and inflammatory cytokines, reducing cellular damage and aging-related dysfunction. Additionally, OS-01 enhances endurance by optimizing energy substrate utilization and preserving glycogen stores during exercise. It plays a protective role in renal and cardiovascular systems by attenuating fibrosis, reducing endothelial dysfunction, and improving mitochondrial efficiency. Preclinical studies suggest its potential in managing metabolic disorders, including type 2 diabetes, obesity, and cardiovascular diseases, by improving glucose homeostasis and reducing insulin resistance. Furthermore, OS-01’s activation of autophagy contributes to neuroprotection, reducing age-related neurodegeneration. Its multifaceted mechanism positions it as a promising candidate for therapeutic intervention in metabolic and age-related diseases.

GHK-Cu is a small, naturally occurring peptide with the ability to attenuate inflammation, improve antioxidant responses, and improve gene expression on a large scale. Research shows that this copper-chelating peptide may be of critical importance both in the prevention of neurodegenerative disease and as a tool for exploring pathophysiological mechanisms. Studies in mice have revealed that GHK-Cu can protect against neurological insults, improve wound healing, reduce rates of infection, and boost blood vessel growth. The peptide has been of interest in recent years for its anti-oxidant properties that, in combination with its ability to alter gene expression patterns, appear to help slow or even reverse some aspects of aging.

BPC-157 is a penta-decapeptide composed of 15 amino acids. It is a partial sequence of the body protection compound (BPC) that was discovered in and isolated from human gastric juice. Animal studies have shown it to accelerate the healing of many different wounds, including muscle, tendon and damaged ligaments. Additionally, BPC 157 has shown to protect organs and aids in the prevention of gastric ulcers. BPC-157 acts systemically in the digestive tract to combat leaky gut, IBS, gastro-intestinal cramps, and Crohn’s disease. This peptide has been known to exhibit analgesic characteristics. Research has shown its ability to help skin burns heal at a faster rate by increasing blood flow to damaged tissues. BPC-157 significantly accelerates reticulin and collagen formation as well as angiogenesis together with stimulation of macrophages and fibroblasts infiltration representing a potential therapeutic tool in wound healing management. Click Here BPC-157 10mg Click Here BPC-157 15mg